A two-stage association study identifies methyl-CpG-binding domain protein 2 gene polymorphisms as candidates for breast cancer susceptibility
- PMID: 22258532
- PMCID: PMC3355265
- DOI: 10.1038/ejhg.2011.273
A two-stage association study identifies methyl-CpG-binding domain protein 2 gene polymorphisms as candidates for breast cancer susceptibility
Abstract
Genome-wide association studies for breast cancer have identified over 40 single-nucleotide polymorphisms (SNPs), a subset of which remains statistically significant after genome-wide correction. Improved strategies for mining of genome-wide association data have been suggested to address heritable component of genetic risk in breast cancer. In this study, we attempted a two-stage association design using markers from a genome-wide study (stage 1, Affymetrix Human SNP 6.0 array, cases=302, controls=321). We restricted our analysis to DNA repair/modifications/metabolism pathway related gene polymorphisms for their obvious role in carcinogenesis in general and for their known protein-protein interactions vis-à-vis, potential epistatic effects. We selected 22 SNPs based on linkage disequilibrium patterns and high statistical significance. Genotyping assays in an independent replication study of 1178 cases and 1314 controls were attempted using Sequenom iPLEX Gold platform (stage 2). Six SNPs (rs8094493, rs4041245, rs7614, rs13250873, rs1556459 and rs2297381) showed consistent and statistically significant associations with breast cancer risk in both stages, with allelic odds ratios (and P-values) of 0.85 (0.0021), 0.86 (0.0026), 0.86 (0.0041), 1.17 (0.0043), 1.20 (0.0103) and 1.13 (0.0154), respectively, in combined analysis (N=3115). Of these, three polymorphisms were located in methyl-CpG-binding domain protein 2 gene regions and were in strong linkage disequilibrium. The remaining three SNPs were in proximity to RAD21 homolog (S. pombe), O-6-methylguanine-DNA methyltransferase and RNA polymerase II-associated protein 1. The identified markers may be relevant to breast cancer susceptibility in populations if these findings are confirmed in independent cohorts.
Figures
Similar articles
-
Assessing SNP-SNP interactions among DNA repair, modification and metabolism related pathway genes in breast cancer susceptibility.PLoS One. 2013 Jun 3;8(6):e64896. doi: 10.1371/journal.pone.0064896. Print 2014. PLoS One. 2013. PMID: 23755158 Free PMC article.
-
Potential novel candidate polymorphisms identified in genome-wide association study for breast cancer susceptibility.Hum Genet. 2011 Oct;130(4):529-37. doi: 10.1007/s00439-011-0973-1. Epub 2011 Mar 19. Hum Genet. 2011. PMID: 21424380 Free PMC article.
-
A genome-wide association study to identify genetic susceptibility loci that modify ductal and lobular postmenopausal breast cancer risk associated with menopausal hormone therapy use: a two-stage design with replication.Breast Cancer Res Treat. 2013 Apr;138(2):529-542. doi: 10.1007/s10549-013-2443-z. Epub 2013 Feb 20. Breast Cancer Res Treat. 2013. PMID: 23423446 Free PMC article.
-
Genome-wide association study identifies breast cancer risk variant at 10q21.2: results from the Asia Breast Cancer Consortium.Hum Mol Genet. 2011 Dec 15;20(24):4991-9. doi: 10.1093/hmg/ddr405. Epub 2011 Sep 9. Hum Mol Genet. 2011. PMID: 21908515 Free PMC article.
-
MMP9 polymorphisms and breast cancer risk: a report from the Shanghai Breast Cancer Genetics Study.Breast Cancer Res Treat. 2011 Apr;126(2):507-13. doi: 10.1007/s10549-010-1119-1. Epub 2010 Aug 20. Breast Cancer Res Treat. 2011. PMID: 20725776 Free PMC article.
Cited by
-
Assessing SNP-SNP interactions among DNA repair, modification and metabolism related pathway genes in breast cancer susceptibility.PLoS One. 2013 Jun 3;8(6):e64896. doi: 10.1371/journal.pone.0064896. Print 2014. PLoS One. 2013. PMID: 23755158 Free PMC article.
-
Beyond the marks: reader-effectors as drivers of epigenetics and chromatin engineering.Trends Biochem Sci. 2022 May;47(5):417-432. doi: 10.1016/j.tibs.2022.03.002. Trends Biochem Sci. 2022. PMID: 35427480 Free PMC article. Review.
-
Functional Profiling of Human MeCP2 by Automated Data Comparison Analysis and Computerized Expression Pathway Modeling.Healthc Inform Res. 2016 Apr;22(2):120-8. doi: 10.4258/hir.2016.22.2.120. Epub 2016 Apr 30. Healthc Inform Res. 2016. PMID: 27200222 Free PMC article.
-
Germline DNA copy number aberrations identified as potential prognostic factors for breast cancer recurrence.PLoS One. 2013;8(1):e53850. doi: 10.1371/journal.pone.0053850. Epub 2013 Jan 16. PLoS One. 2013. PMID: 23342018 Free PMC article.
-
Rett syndrome and MeCP2.Neuromolecular Med. 2014 Jun;16(2):231-64. doi: 10.1007/s12017-014-8295-9. Epub 2014 Mar 11. Neuromolecular Med. 2014. PMID: 24615633 Free PMC article. Review.
References
-
- Byrne C, Brinton LA, Haile RW, Schairer C. Heterogeneity of the effect of family history on breast cancer risk. Epidemiology. 1991;2:276–284. - PubMed
-
- Hall JM, Lee MK, Newman B, et al. Linkage of early-onset familial breast cancer to chromosome 17q21. Science. 1990;250:1684–1689. - PubMed
-
- Wooster R, Neuhausen SL, Mangion J, et al. Localization of a breast cancer susceptibility gene, BRCA2, to chromosome 13q12–13. Science. 1994;265:2088–2090. - PubMed
-
- Renwick A, Thompson D, Seal S, et al. ATM mutations that cause ataxia-telangiectasia are breast cancer susceptibility alleles. Nat Genet. 2006;38:873–875. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials